Newsroom

Sorted by: Latest

-

GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the strategic expansion of its Regulatory Affairs & Quality department with two senior appointments following recent regulatory milestones. The company named...
-

GenSight Biologics Renforce son Équipe Réglementaire aux États-Unis et en Europe avec Deux Nominations au sein de sa Direction

PARIS--(BUSINESS WIRE)--Regulatory News : GenSight Biologics (« GenSight Biologics » ou la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le traitement des maladies neurodégénératives de la rétine et du système nerveux central, annonce aujourd’hui le renforcement stratégique de son département des Affaires Réglementaires et de la Qualité avec deux nomination...
-

BEYOND Developments Unveils EVERMORE Masterplan on Marjan Beach in Ras Al Khaimah

RAS AL KHAIMAH, United Arab Emirates--(BUSINESS WIRE)--BEYOND Developments Unveils EVERMORE Masterplan on Marjan Beach in Ras Al Khaimah...
-

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

MARSEILLE, France--(BUSINESS WIRE)--Innate pharma to participate in the Leerink Partners Global Healthcare Conference...
-

Innate Pharma participera à la conférence Leerink Partners Global Healthcare

MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société »), une société de biotechnologies au stade clinique qui développe des traitements d’immunothérapies contre le cancer, annonce aujourd’hui que des membres de son équipe de direction participeront à une discussion (« fireside chat ») ainsi qu’à des réunions individuelles lors de la conférence suivante : Leerink Partners Global Healthcare Conference 2026 Dates : du 8 au...
-

Yubico anuncia la disponibilidad de la serie YubiKey 5 CCN, la primera llave de seguridad física en obtener la clasificación «ENS Alta» en el catálogo CPSTIC del CCN en España

ESTOCOLMO--(BUSINESS WIRE)--Yubico (NASDAQ ESTOCOLMO: YUBICO), una moderna empresa de ciberseguridad y creadora de las claves de acceso más seguras, ha anunciado hoy la disponibilidad de la serie YubiKey 5 CCN en España. Diseñada específicamente para el mercado español, la serie figura ahora oficialmente en el Catálogo de Productos y Servicios de Tecnología de la Información y la Comunicación del Centro Criptológico Nacional (CCN) español. Tras una rigurosa evaluación LINCE, la serie YubiKey 5...
-

Sandisk Announces Pricing of Secondary Offering of Common Stock

MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (Nasdaq: SNDK) (the “Company” or “Sandisk”) announced today the pricing of a secondary public offering (the “Offering”) of 5,821,135 shares of its common stock (the “SNDK Shares”) currently owned by Western Digital Corporation, the Company’s former parent (“WDC”). The SNDK Shares will be offered at a public offering price of $545.00 per share. Sandisk is not selling any shares of common stock and will not receive any proceeds from the sale...
-

California AB 1997 (Lee, D-Milpitas) Speeds Permitting, Spurs Housing at Local Level  

SACRAMENTO, Calif.--(BUSINESS WIRE)--California AB 1997 (Lee, D-Milpitas) Speeds Permitting, Spurs Housing at Local Level...
-

Alcoa Furthers Approvals Modernization with Australian Government

PERTH, Australia--(BUSINESS WIRE)--Alcoa Corporation (NYSE: AA, ASX: AAI) (“Alcoa” or the “Company”), today announced Alcoa of Australia has agreed with the Australian Federal Government to further modernize the approvals framework for its Western Australian mining activities under Australia’s federal Environment Protection and Biodiversity Conservation Act (EPBC Act). Alcoa of Australia will undertake a Strategic Assessment of current and potential future mining areas through to 2045, supporte...
-

Riassunto: ChipAgents ottiene un finanziamento da 74 milioni di dollari per l'espansione della sua piattaforma AI agentica mirata a velocizzare la progettazione dei chip

SANTA CLARA, California--(BUSINESS WIRE)--ChipAgents, leader nelle piattaforme per l'AI agentica destinata al settore della progettazione dei semiconduttori, ha annunciato la chiusura (con eccesso di sottoscrizioni) di un round di finanziamento di serie A1 del valore di 50 milioni di dollari USA, che porta a 74 milioni di dollari il totale del capitale raccolto. Il round era guidato da Matter Venture Partners, azienda di venture capital HardTech supportata da TSMC, con la partecipazione degli i...